Boston Life Sciences License Amendment January 2004 HU 1615License Agreement • August 15th, 2005 • Boston Life Sciences Inc /De • Pharmaceutical preparations
This Amendment to the License Agreement (this “Amendment”) effective the last day signed below of 2004, is entered into by and between Boston Life Sciences, Inc, a corporation organized and existing under the laws of Massachusetts having its principal offices at 20 Newbury St., 8th Floor, Boston, MA 02116, (hereinafter, “LICENSEE”) and The President and Fellows of Harvard College, a charitable corporation of Massachusetts, having an office at Office of Technology Licensing and Industry Sponsored Research, Harvard Medical School, Gordon Hall of Medicine, Room 414, 25 Shattuck Street, Boston, MA 02115 (hereinafter “HARVARD”).
CONSULTING AGREEMENTConsulting Agreement • August 15th, 2005 • Boston Life Sciences Inc /De • Pharmaceutical preparations
This consulting agreement (this “Agreement”) is made effective for all purposes and in all respects as of the date last signed, by and between Boston Life Sciences, Inc., a Delaware BLSI with its principal offices located at 20 Newbury Street, 5th Floor, Boston MA 02116 (hereinafter “BLSI”), and Marc E. Lanser, M.D. of Fayston, Vermont (hereinafter referred to as “Consultant”).
Boston Life Science Licenses Amendment January 2004 HU 919License Agreement • August 15th, 2005 • Boston Life Sciences Inc /De • Pharmaceutical preparations
This Amendment to the License Agreement (this “Amendment”) effective the last day signed below of 2004, is entered into by and between Boston Life Sciences, Inc, a corporation organized and existing under the laws of Massachusetts having its principal offices at 20 Newbury St., 8th Floor, Boston, MA 02116, (hereinafter, “LICENSEE”) and The President and Fellows of Harvard College, a charitable corporation of Massachusetts, having an office at Office of Technology Licensing and Industry Sponsored Research, Harvard Medical School, Gordon Hall of Medicine, Room 414, 25 Shattuck Street, Boston, MA 02115 (hereinafter “HARVARD”).
SEVERANCE AND SETTLEMENT AGREEMENT AND RELEASESeverance and Settlement Agreement and Release • August 15th, 2005 • Boston Life Sciences Inc /De • Pharmaceutical preparations • Massachusetts
AGREEMENT made as of the 9th day of June, 2005 (the “Agreement”) by and between Boston Life Sciences, Inc., a Delaware corporation (the “Company”) and Marc E. Lanser, M.D. of Fayston, Vermont (the “Executive”).
LEASELease • August 15th, 2005 • Boston Life Sciences Inc /De • Pharmaceutical preparations
AMENDMENT TO LICENSE AGREEMENT (Agreement number 2639; CMCC 600)License Agreement • August 15th, 2005 • Boston Life Sciences Inc /De • Pharmaceutical preparations
WHEREAS, CHILDREN’S MEDICAL CENTER CORPORATION (“CMCC”), a corporation organized and existing under the laws of the Commonwealth of Massachusetts and having its principal place of business at 300 Longwood Avenue, Boston, MA 02115, and BOSTON LIFE SCIENCES INC. (“Company”), a corporation organized and existing under the laws of Delaware, and having its principal place of business at 20 Newbury Street, Boston, Massachusetts 02116, entered into a License Agreement effective as of December 15, 1998 (hereinafter “the Inosine License Agreement”), in which CMCC granted certain license rights to Company under patent rights relating to “Methods for Modulating the Axonal Outgrowth of Central Nervous System Neurons”, CMCC Case 600, by Dr. Larry Benowitz; and
